News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
19,717 Results
Type
Article (2065)
Company Profile (13)
Press Release (17639)
Section
Business (5920)
Career Advice (62)
Deals (789)
Drug Development (3271)
Employer Resources (3)
FDA (591)
Job Trends (759)
News (10263)
Policy (730)
Tag
Academia (281)
Alliances (1730)
ALS (8)
Alzheimer's disease (288)
Approvals (589)
Artificial intelligence (16)
Best Places to Work (739)
Biotechnology (11)
Cancer (33)
Career advice (49)
Cell therapy (10)
Clinical research (2544)
Collaboration (50)
Compensation (9)
COVID-19 (44)
C-suite (13)
Data (85)
Depression (27)
Diagnostics (68)
Duchenne muscular dystrophy (6)
Earnings (1355)
Events (2776)
Executive appointments (37)
FDA (629)
Funding (35)
Gene therapy (8)
GLP-1 (24)
Government (75)
Healthcare (572)
Immunology and inflammation (6)
Infectious disease (44)
Inflammatory bowel disease (9)
Interviews (12)
IPO (301)
Job creations (92)
Job search strategy (45)
Layoffs (23)
Legal (91)
Medical device (254)
Medtech (255)
Mergers & acquisitions (518)
Metabolic disorders (8)
Multiple sclerosis (13)
Neurodegenerative disease (17)
Neuropsychiatric disorders (11)
Neuroscience (436)
NextGen: Class of 2025 (231)
Non-profit (217)
Northern California (83)
Opinion (8)
Pain (6)
Parkinson's disease (35)
Patents (6)
People (2531)
Phase I (574)
Phase II (950)
Phase III (1161)
Pipeline (37)
Postmarket research (133)
Preclinical (375)
Psychedelics (8)
Radiopharmaceuticals (6)
Rare diseases (14)
Real estate (150)
Regulatory (631)
Research institute (235)
Resumes & cover letters (9)
Schizophrenia (35)
Series A (10)
Southern California (142)
Startups (144)
United States (900)
Vaccines (8)
Date
Today (17)
Last 7 days (50)
Last 30 days (132)
Last 365 days (1582)
2025 (279)
2024 (1573)
2023 (1665)
2022 (1853)
2021 (2030)
2020 (1585)
2019 (1357)
2018 (1037)
2017 (1050)
2016 (1058)
2015 (1216)
2014 (870)
2013 (642)
2012 (614)
2011 (532)
2010 (457)
Location
Africa (17)
Asia (1359)
Australia (179)
California (255)
Canada (96)
China (24)
Colorado (7)
Connecticut (22)
Europe (3227)
Florida (50)
Illinois (61)
Indiana (17)
Japan (8)
Maryland (32)
Massachusetts (205)
Minnesota (10)
New Jersey (49)
New York (90)
North Carolina (12)
Northern California (83)
Ohio (7)
Pennsylvania (57)
South America (18)
Southern California (142)
Texas (12)
Utah (7)
Washington State (12)
19,717 Results for "amygdala neurosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioCapital
ABMRF Invests in Amygdala Neurosciences to Develop ANS-858 for Alcohol Use Disorder
Amygdala Neurosciences announced that the Company has closed a new round of equity financing led by ABMRF, the Alcohol Beverage Medicines Research Foundation to fund the Company’s IND-stage activities for ANS-858.
May 14, 2024
·
4 min read
Biotech Bay
Amygdala Neurosciences Awarded $2.0 million NIH Grant to Conduct IND Enabling Studies
Amygdala Neurosciences has been awarded a $2.0 million NIH grant to support the project titled “Investigational New Drug -enabling and Early-Stage Development of Selective, Reversible, Orally Bioavailable ALDH2 inhibitor ANS-00858 to Treat Alcohol Use Disorder.”
August 1, 2023
·
3 min read
Press Releases
Gate Neurosciences Strengthens Focus on the Synapse as a Therapeutic Target with Acquisition of Boost Neuroscience
February 19, 2025
·
4 min read
Press Releases
Firefly Neuroscience Accepted into NVIDIA Connect Program
February 11, 2025
·
5 min read
Press Releases
Alto Neuroscience to Participate in Upcoming March 2025 Investor Conferences
February 26, 2025
·
1 min read
Press Releases
Vistagen to Present at the 2024 Neuroscience Education Institute Congress
November 5, 2024
·
6 min read
Press Releases
Evotec Announces Key Progress in Neuroscience Collaboration with Bristol Myers Squibb
March 4, 2025
·
4 min read
Press Releases
ProMIS Neurosciences Issues Letter to Shareholders
January 14, 2025
·
9 min read
Press Releases
ProMIS Neurosciences to Participate in Guggenheim Securities SMID Cap Biotech Conference
January 29, 2025
·
1 min read
Press Releases
Myosin Therapeutics Closes Second Seed Round to Advance Clinical Trials for Innovative Cancer and Neuroscience Therapies
March 4, 2025
·
2 min read
1 of 1,972
Next